Skip to Content
Morningstar

Evotec SE EVT

Morningstar Rating
Unlock
Stock XETR Rating as of
€9.76 −0.14 (1.36%)
View Full Chart
As of Delayed Price Closed
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Demand for Biologics CDMO Services Continues to Spur Growth, as Evotec Focuses on Profitability

Rachel Elfman, Ava Gams

Evotec is a drug discovery partnership firm that has a contract development and manufacturing organization, or CDMO, business, in addition to an innovative drug development program focused on collaboration with clients. The firm offers services across a variety of therapeutic areas and serves a diverse client base of large and midsize pharmaceutical and biotechnology companies. Following a recent period of investment that has weighed on returns, Evotec appears well positioned to mature and stabilize its business as its strategic growth initiatives materialize.

Read Full Report

Price vs Fair Value

View History
EVT is trading at a 30% discount.
Price
€9.76
Fair Value
€46.00
Uncertainty
High
1-Star Price
€22.20
5-Star Price
€7.10
Economic Moat
Rvckq
Capital Allocation
Xzbzfwx

Bulls Say, Bears Say

Bulls

Evotec’s focus on building out its biologics manufacturing capacity makes it well positioned to capture heightened demand for biologics by biopharma companies.

Bears

Competitive market dynamics remain fierce, weighing on Evotec’s organic growth in the Execute segment and putting pricing pressure on the firm’s more commoditized services.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if EVT is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
€9.90
Day Range
€9.72–10.07
52-Week Range
€8.52–24.44
Bid/Ask
€0.00 / €0.00
Market Cap
€1.73 Bil
Volume/Avg
1.9 Mil / 1.3 Mil

Key Statistics

Price/Earnings (Normalized)
21.03
Price/Sales
2.21
Dividend Yield (Trailing)
—
Dividend Yield (Forward)
—
Total Yield
—

Company Profile

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The EVT Execute segment, about 65% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis or integrated drug discovery collaborations. The EVT Innovate segment, about 35% of sales, develops proprietary drug discovery programs and assets, which can lead to partnerships with clients. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
5,086
Website
https://www.evotec.com

Competitors

Valuation

View More
Metric
EVT
CTLT
LONN
Price/Earnings (Normalized)
 21.0399.2032.40
Price/Book Value
 1.542.773.96
Price/Sales
 2.212.505.70
Price/Cash Flow
 51.5054.8428.76
Price/Earnings
EVT
CTLT
LONN

Financial Strength

Metric
EVT
CTLT
LONN
Quick Ratio
 1.931.541.12
Current Ratio
 2.162.481.77
Interest Coverage
 −6.83−5.239.00
Quick Ratio
EVT
CTLT
LONN

Profitability

Metric
EVT
CTLT
LONN
Return on Assets (Normalized)
 −4.21%−2.51%5.28%
Return on Equity (Normalized)
 −8.08%−6.08%9.02%
Return on Invested Capital (Normalized)
 −5.57%−0.60%7.29%
Return on Assets
EVT
CTLT
LONN
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Drug Manufacturers - Specialty & Generic Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AYrrvvhgbtkBwc$76.2 Bil
MKKGY
Merck KGaA ADRDghyywswhFqltlm$70.9 Bil
HLN
Haleon PLC ADRGzqbgtntDpwc$37.8 Bil
VTRS
Viatris IncRfyvcrbvRqfn$14.0 Bil
RDY
Dr Reddy's Laboratories Ltd ADRYxxfykpnMpp$12.7 Bil
CTLT
Catalent IncVbbkbgrxhBrfqmzh$10.2 Bil
PRGO
Perrigo Co PLCQcpjxyywMpm$4.4 Bil
CURLF
Curaleaf Holdings IncSqdxhqdPglwk$4.1 Bil
PBH
Prestige Consumer Healthcare IncKtmtsshvYgwvqbd$3.5 Bil
GTBIF
Green Thumb Industries IncVrqqlgwhzhHmkp$3.1 Bil

Sponsor Center